J Cardiothorac Vasc Anesth. 1994 Oct;8(5):532-5. Unique Identifier :
Lymphocytes and their subset counts were determined in 30 cardiac
surgery patients during cardiopulmonary bypass (CPB) with or without use
of an autotransfusion device. In the autotransfusion group, centrifuged
and washed autologous red blood cells (median 400 mL [range 200-770 mL])
and in the control group corresponding amounts of homologous packed red
blood cells (median 500 mL [range 250-750 mL]) were transfused after
declamping the aorta. The percentages of T lymphocytes (CD3) and T
cytotoxic cells (CD8) increased in both groups (CD3 up to 5%, P < 0.05
and CD8 up to 35%, P < 0.01), but the percentage of T helper cells (CD4)
did not change. The ratio of CD4/CD8 cells decreased (up to 34%, P <
0.01). The percentage of naive resting T cells (CD45RA) increased
slightly (up to 8%, P < 0.05) whereas the percentages of memory T cells
(CD45RO), T cells with IL-2 receptor (CD25), and natural killer cells
(CD16) remained unaltered. The percentage of HLA-DR positive lymphocytes
increased during CPB (up to 18%, P < 0.05), but it was decreased
thereafter (up to 16%, P < 0.05). The percentage of monocytes (CD14)
decreased first during CPB in both groups (up to 32%, P < 0.01), but it
was higher in the autotransfusion device group (decreased 29% from
initial value) than in the control group (decreased 65% from initial
value) at the end of CPB (P < 0.05). This study shows that
extracorporeal circulation has an effect on lymphocytes and their subset
counts. The changes were slightly immunosuppressive. By contrast, use of
autotransfusion devices had only minor effects.
Blood Transfusion Blood Transfusion, Autologous/*INSTRUMENTATION
*Cardiopulmonary Bypass CD4-CD8 Ratio CD4-Positive
T-Lymphocytes/PATHOLOGY CD8-Positive T-Lymphocytes/PATHOLOGY Female
Human HLA-DR Antigens/ANALYSIS Immunologic Memory Killer Cells,
Natural/PATHOLOGY Leukocyte Count *Lymphocyte Count Lymphocyte
Subsets/*PATHOLOGY Lymphocyte Transformation Lymphocytes/*PATHOLOGY
Male Middle Age Monocytes/PATHOLOGY Receptors, Interleukin-2/ANALYSIS
Support, Non-U.S. Gov't T-Lymphocytes/*PATHOLOGY T-Lymphocytes,
Cytotoxic/PATHOLOGY T-Lymphocytes, Helper-Inducer/PATHOLOGY JOURNAL
ARTICLE